Year archive

Inify Laboratories AB — 2025 filings

All 128 regulatory filings released by Inify Laboratories AB (INIFY) in 2025, sourced directly from the official regulator.

128 Filings

2025 Period

2025 filings (128)

Filing	Released	Lang
Inify Laboratories - mandatory notification of trade - Attachment: Inify_Laboratories_PDMR_attachment.pdf Director's Dealing	2025-12-19	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2025-12-19	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2025-12-19	English
Inify Laboratories announces final results of fully guaranteed private placement Capital/Financing Update	2025-12-19	English
Inify Laboratories announces final results of fully guaranteed private placement - Attachment: Inify_laboratories_Final_results_private_placement.pdf Capital/Financing Update	2025-12-19	English
Inify Laboratories announces final results of fully guaranteed private placement Capital/Financing Update	2025-12-19	English
Inify Laboratories - mandatory notification of trade - Attachment: Mandatory_notification_of_trade_2025_12_19.pdf Director's Dealing	2025-12-19	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2025-12-19	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2025-12-19	English
Inify Laboratories: Key information regarding Repair Issue - Attachment: Inify_Laboratories_Key_information_regarding_Repair_Issue.pdf Capital/Financing Update	2025-12-17	English
Inify Laboratories: Key information regarding Repair Issue Share Issue/Capital Change	2025-12-17	English
Inify Laboratories: Key information regarding Repair Issue Capital/Financing Update	2025-12-17	English
Inify Laboratories announces preliminary results of fully guaranteed private placement - Attachment: Inify_Laboratories_preliminary_results_private_placement.pdf Capital/Financing Update	2025-12-17	English
Inify Laboratories announces preliminary results of fully guaranteed private placement Capital/Financing Update	2025-12-17	English
Inify Laboratories announces preliminary results of fully guaranteed private placement Capital/Financing Update	2025-12-17	English
Inify Laboratories - notification of trade Director's Dealing	2025-12-16	English
Inify Laboratories - notification of trade - Attachment: Notification_of_trade_2025_12_16.pdf Director's Dealing	2025-12-16	English
Inify Laboratories - notification of trade Director's Dealing	2025-12-16	English
Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue - Attachment: Inify_Laboratories_appl_periods_private_placement_and_repair_iss Capital/Financing Update	2025-12-09	English
Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue Capital/Financing Update	2025-12-09	English
Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue Capital/Financing Update	2025-12-09	English
Kommuniké från extra bolagsstämma i Inify Laboratories AB - Attachment: Inify_Laboratories_Kommunike_fran_extra_bolagsstamma_4_december_2025.pdf AGM Information	2025-12-04	Swedish
Bulletin from the extraordinary general meeting of Inify Laboratories AB - Attachment: Inify_Laboratories_Bulletin_from_EGM_December_4_2025.pdf Capital/Financing Update	2025-12-04	English
Kommuniké från extra bolagsstämma i Inify Laboratories AB Capital/Financing Update	2025-12-04	Swedish
Bulletin from the extraordinary general meeting of Inify Laboratories AB Share Issue/Capital Change	2025-12-04	English
Kommuniké från extra bolagsstämma i Inify Laboratories AB AGM Information	2025-12-04	Swedish
Bulletin from the extraordinary general meeting of Inify Laboratories AB Capital/Financing Update	2025-12-04	English
Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue - Attachment: Inify_Laboratories_Updated_timetable_for_settlement.pdf Share Issue/Capital Change	2025-12-03	English
Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue Share Issue/Capital Change	2025-12-03	English
Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue Share Issue/Capital Change	2025-12-03	English
Financial calendar Report Publication Announcement	2025-11-28	English
Finansiell kalender Report Publication Announcement	2025-11-28	Norwegian
Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025 - Attachment: Inify_Laboratories_EGM_notice_December_4_2025.pdf Proxy Solicitation & Information Statement	2025-11-12	English
Inify Laboratories - kallelse till extra bolagsstämma 4 december 2025 - Attachment: Inify_Laboratories_EGM_kallelse_December_4_2025.pdf Proxy Solicitation & Information Statement	2025-11-12	Swedish
Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025 AGM Information	2025-11-12	English
Inify Laboratories - kallelse till extra bolagsstämma 4 december 2025 AGM Information	2025-11-12	Swedish
Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025 Proxy Solicitation & Information Statement	2025-11-12	English
Inify Laboratories – kallelse till extra bolagsstämma 4 december 2025 Proxy Solicitation & Information Statement	2025-11-12	Swedish
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million - Attachment: Inify_Laboratories_EGM_kallelse_December_4_2025.pd Proxy Solicitation & Information Statement	2025-11-12	Swedish
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million Share Issue/Capital Change	2025-11-12	English
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million - Attachment: Inify_Laboratories_EGM_notice_December_4_2025.pdf Proxy Solicitation & Information Statement	2025-11-12	English
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million Share Issue/Capital Change	2025-11-12	English
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million Proxy Solicitation & Information Statement	2025-11-12	English
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million Proxy Solicitation & Information Statement	2025-11-12	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q3 2025	2025-10-29	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q3 2025	2025-10-29	English
Korrigering - Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats och den kliniska verksamheten i Storbritannien är på god väg mot öppning i början av 2026 - Attachment: Inif Interim / Quarterly Report Q3 2025	2025-10-29	Swedish
Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 - Attachment: Inify_Laboratories_Financial_Report_Q3_2025.pdf Interim / Quarterly Report Q3 2025	2025-10-29	English
Correction - Inify Laboratories: Første gastrointestinale diagnoser levert og klinisk virksomhet i Storbritannia i rute mot lansering tidlig i 2026 - Attachment: Inify_Laboratories_Financial_Report_Q3 Interim / Quarterly Report Q3 2025	2025-10-29	English
Korrigering - Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats och den kliniska verksamheten i Storbritannien är på god väg mot öppning i början av 2026 Earnings Release Q3 2025	2025-10-29	Swedish
Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 Earnings Release Q3 2025	2025-10-29	English
Correction - Inify Laboratories: Første gastrointestinale diagnoser levert og klinisk virksomhet i Storbritannia i rute mot lansering tidlig i 2026 Earnings Release Q3 2025	2025-10-29	Norwegian
Inify Laboratories: Første gastrointestinale diagnoser levert og klinisk virksomhet i Storbritannia i rute mot lansering tidlig i 2026 - Attachment: Inify_Laboratories_Financial_Report_Q3_2025.pdf Interim / Quarterly Report Q3 2025	2025-10-29	English
Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 - Attachment: Inify_Laboratories_Financial_Report_Q3_2025.pdf Interim / Quarterly Report Q3 2025	2025-10-29	English
Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats och den kliniska verksamheten i Storbritannien är på god väg mot öppning i början av 2026 - Attachment: Inify_Laboratories Interim / Quarterly Report Q3 2025	2025-10-29	Swedish
Inify Laboratories: Første gastrointestinale diagnoser levert og klinisk virksomhet i Storbritannia i rute mot lansering tidlig i 2026 Earnings Release Q3 2025	2025-10-29	Norwegian
Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 Earnings Release Q3 2025	2025-10-29	English
Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats och den kliniska verksamheten i Storbritannien är på god väg mot öppning i början av 2026 Earnings Release Q3 2025	2025-10-29	Swedish
Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 Interim / Quarterly Report Q3 2025	2025-10-29	English
Inify Laboratories: Første gastrointestinale diagnoser levert og klinisk virksomhet i Storbritannia i rute mot lansering tidlig i 2026 Interim / Quarterly Report Q3 2025	2025-10-29	English
Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats och den kliniska verksamheten i Storbritannien är på god väg mot öppning i början av 2026 Interim / Quarterly Report Q3 2025	2025-10-29	Swedish
Inify Laboratories - mandatory notification of trade Director's Dealing	2025-08-29	English
Inify Laboratories: Stabil tillväxt i Sverige och första patientdiagnostiken levererad i Storbritannien - Attachment: Inify_Laboratories_Delarsrapport_Q2_2025.pdf Interim / Quarterly Report Q2 2025	2025-08-27	Swedish
Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK - Attachment: Inify_Laboratories_Financial_Report_Q2_2025.pdf Interim / Quarterly Report Q2 2025	2025-08-27	English
Inify Laboratories: Sterk vekst i Sverige og første pasientdiagnostikk levert i Storbritannia - Attachment: Inify_Laboratories_Financial_Report_Q2_2025.pdf Interim / Quarterly Report Q2 2025	2025-08-27	English
Inify Laboratories: Stabil tillväxt i Sverige och första patientdiagnostiken levererad i Storbritannien Earnings Release Q2 2025	2025-08-27	Swedish
Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK Earnings Release H1 2025	2025-08-27	English
Inify Laboratories: Sterk vekst i Sverige og første pasientdiagnostikk levert i Storbritannia Earnings Release Q2 2025	2025-08-27	Norwegian
Interim / Quarterly Report 2025 Interim / Quarterly Report Q2 2025	2025-08-27	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q2 2025	2025-08-27	English
Inify Laboratories AB (publ) – summary of Annual General Meeting AGM Information	2025-05-21	English
Inify Laboratories AB (publ) – kommuniké från årsstämma AGM Information	2025-05-21	Swedish
Inify Laboratories AB (publ) - summary of Annual General Meeting AGM Information	2025-05-21	English
Inify Laboratories AB (publ) - kommuniké från årsstämma AGM Information	2025-05-21	Swedish
Inify Laboratories AB (publ) - summary of Annual General Meeting AGM Information	2025-05-21	English
Inify Laboratories AB (publ) - kommuniké från årsstämma AGM Information	2025-05-21	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q1 2025	2025-04-30	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q1 2025	2025-04-30	English
Inify Laboratories: Continued strong growth - construction and establishment in the UK Interim / Quarterly Report Q1 2025	2025-04-30	English
Inify Laboratories: Fortsatt stark tillväxt - uppbyggnad och etablering i Storbritannien Interim / Quarterly Report Q1 2025	2025-04-30	Swedish
Inify Laboratories: Fortsatt sterk vekst - bygging og etablering i Storbritannia Interim / Quarterly Report Q1 2025	2025-04-30	English
Inify Laboratories: Continued strong growth - construction and establishment in the UK Earnings Release Q1 2025	2025-04-30	English
Inify Laboratories: Fortsatt stark tillväxt - uppbyggnad och etablering i Storbritannien Earnings Release Q1 2025	2025-04-30	Swedish
Inify Laboratories: Fortsatt sterk vekst - bygging og etablering i Storbritannia Earnings Release Q1 2025	2025-04-30	Norwegian
Inify Laboratories – notice of Annual General Meeting on May 20, 2025 Proxy Solicitation & Information Statement	2025-04-16	English
Inify Laboratories – kallelse till årsstämma den 20 maj 2025 Proxy Solicitation & Information Statement	2025-04-16	Swedish
Inify Laboratories - Årsredovisning 2024 Annual Report FY 2024	2025-04-16	Swedish
Inify Laboratories - Årsredovisning 2024 Report Publication Announcement	2025-04-16	Swedish
Inify Laboratories - kallelse till årsstämma den 20 maj 2025 Governance Information	2025-04-16	Swedish
Inify Laboratories - notice of Annual General Meeting on May 20, 2025 Governance Information	2025-04-16	Swedish
Inify Laboratories - Annual Report 2024 Annual Report FY 2024	2025-04-16	English
Inify Laboratories - kallelse till årsstämma den 20 maj 2025 AGM Information	2025-04-16	Swedish
Inify Laboratories - notice of Annual General Meeting on May 20, 2025 AGM Information	2025-04-16	English
Inify Laboratories - Annual Report 2024 Report Publication Announcement	2025-04-16	English
Inify Laboratories - kallelse till årsstämma den 20 maj 2025 AGM Information	2025-04-16	Swedish
Inify Laboratories - notice of Annual General Meeting on May 20, 2025 AGM Information	2025-04-16	English
Interim / Quarterly Report 2024 Interim / Quarterly Report Q4 2024	2025-02-26	Swedish
Interim / Quarterly Report 2024 Interim / Quarterly Report Q4 2024	2025-02-26	English
Inify Laboratories: Salgsvekst på 60 prosent i 4. kvartal og svært positiv respons på ekspansjonen i Storbritannia Interim / Quarterly Report Q4 2024	2025-02-26	English
Inify Laboratories: 60% försäljningstillväxt och mycket positiv respons på expansionen till Storbritannien Interim / Quarterly Report Q4 2024	2025-02-26	Swedish
Inify Laboratories: Salgsvekst på 60 prosent i 4. kvartal og svært positiv respons på ekspansjonen i Storbritannia Earnings Release Q4 2024	2025-02-26	Norwegian
Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion Interim / Quarterly Report Q4 2024	2025-02-26	English
Inify Laboratories: 60% försäljningstillväxt och mycket positiv respons på expansionen till Storbritannien Earnings Release FY 2024	2025-02-26	Swedish
Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion Earnings Release FY 2024	2025-02-26	English
Inify Laboratories – New share capital registered Share Issue/Capital Change	2025-02-14	English
Inify Laboratories - New share capital registered Share Issue/Capital Change	2025-02-14	English
Inify Laboratories - New share capital registered Share Issue/Capital Change	2025-02-14	English
Inify Laboratories – Resolution to issue new shares in Private Placement and Subsequent Offering Share Issue/Capital Change	2025-02-12	English
Inify Laboratories - Resolution to issue new shares in Private Placement and Subsequent Offering Share Issue/Capital Change	2025-02-12	English
Inify Laboratories - Resolution to issue new shares in Private Placement and Subsequent Offering Capital/Financing Update	2025-02-12	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2025-01-30	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2025-01-30	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2025-01-30	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2025-01-24	English
Inify Laboratories - mandatory notification of trade Director's Dealing	2025-01-24	English
Inify Laboratories - mandatory notification of trade Share Issue/Capital Change	2025-01-24	English
Inify Laboratories – Final results of the Subsequent Offering Capital/Financing Update	2025-01-23	English
Inify Laboratories - Final results of the Subsequent Offering Capital/Financing Update	2025-01-23	English
Inify Laboratories - Final results of the Subsequent Offering Capital/Financing Update	2025-01-23	English
Inify Laboratories – Last day of the subscription period in the Subsequent Offering Capital/Financing Update	2025-01-23	English
Inify Laboratories - Last day of the subscription period in the Subsequent Offering Capital/Financing Update	2025-01-23	English
Inify Laboratories - Last day of the subscription period in the Subsequent Offering Capital/Financing Update	2025-01-23	English
Inify Laboratories – Commencement of subscription period for Subsequent Offering Share Issue/Capital Change	2025-01-09	English
Inify Laboratories – Commencement of subscription period for Subsequent Offering Capital/Financing Update	2025-01-09	English
Inify Laboratories - Commencement of subscription period for Subsequent Offering Capital/Financing Update	2025-01-09	English
Inify Laboratories - Commencement of subscription period for Subsequent Offering Capital/Financing Update	2025-01-09	English
Inify Laboratories – Registration of prospectus and upcoming launch of Subsequent Offering Capital/Financing Update	2025-01-07	English
Inify Laboratories – Registration of prospectus and upcoming launch of Subsequent Offering Capital/Financing Update	2025-01-07	English